RETAMED (Triple Receptor Agonist – GLP-1, GIP & Glucagon)

Description

WHAT IS RETAMED (Triple Receptor Agonist)?

Retamed is a peptide that acts as a triple agonist at three receptors at once: GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide) and the glucagon receptor. The first two regulate appetite and blood sugar. The third is what sets a triple agonist apart from a dual one: glucagon receptor activation raises energy expenditure, so the body burns more while appetite is already reduced. This combination is why Retamed produces the strongest weight-loss effects of the GLP-1 peptide class.

RETAMED BENEFITS

Retamed offers a wide range of effects, including:

Appetite Suppression: The GLP-1 and GIP arms reduce hunger and slow stomach emptying, lowering food intake without constant effort.

Increased Energy Expenditure: The glucagon arm raises resting metabolic rate. This is the mechanism single and dual agonists do not have, and the reason Retamed outperforms them.

Fat Mobilisation: Glucagon receptor activation promotes the breakdown of stored fat in the liver, supporting fat loss rather than general weight loss.

Blood Sugar Regulation: Enhances insulin secretion and improves glucose control, in line with the rest of the GLP-1 class.

RETAMED DOSAGE:

Triple Receptor Agonist 10mg/vial

RETAMED PEPTIDE INJECTIONS PACKAGE CONTENT:

1 Box of 1 Vial

HOW TO USE RETAMED PEPTIDE:

Retamed is injected subcutaneously, generally once per week. Dosages vary between users, it is recommended to start at 2 mg per week and titrate upward slowly, with most users settling between 4 and 8 mg per week. Because the glucagon arm makes it more potent than a single or dual agonist, titrate more slowly than you would with a GLP-1-only peptide and hold each step until side effects settle.